Salient Capital Advisors’s ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B MLPZ Stock Holding History

Salient Capital Advisors’s Portfolio MLPZ Stock Details MLPZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-9,853	Closed	-$494K	–	202
2017 Q2	$494K	Buy	9,853 +2,250	+30%	+$118K	0.01%	150
2017 Q1	$441K	Buy	7,603 +210	+3%	+$12.5K	0.01%	188
2016 Q4	$422K	Buy	7,393 +241	+3%	+$12.9K	0.01%	193
2016 Q3	$397K	Buy	7,152 +1,247	+21%	+$67.9K	0.01%	185
2016 Q2	$326K	Buy	+5,905	New	+$272K	0.01%	205

Salient Capital Advisors's MLPZ Position: Q3 2017 in Review

Salient Capital Advisors sold out of ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B (MLPZ) in Q3 2017, closing a stake of 9,853 shares — an estimated $494K sold.

Salient Capital Advisors first reported a position in MLPZ in Q2 2016 and held it in 5 quarters. The position peaked at $494K in Q2 2017. 0 funds tracked by Wall St. Rank hold MLPZ as of Q3 2017.

Salient Capital Advisors reported no remaining ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B position as of Q3 2017 after selling out during the quarter.
Salient Capital Advisors sold 9,853 ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B shares in Q3 2017, an estimated $494K.
Salient Capital Advisors first reported a position in ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B in Q2 2016 and held it in 5 quarters.
Salient Capital Advisors's ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B position peaked at $494K in Q2 2017.
0 funds tracked by Wall St. Rank held ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.